BackBecton Dickinson Overview
Becton Dickinson & Co.

Becton Dickinson Target Price

See Becton Dickinson's analyst price targets ($180) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$165.62

Average Target Price

$179.178.2% upside

6 analysts in the last 4 months

High: $204 | Low: $159

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-28UBS$19014.7% upsideOpen
2026-07-06Evercore ISI$1808.7% upsideOpen
2026-05-11Barclays$20423.2% upsideOpen
2026-04-17Piper SandlerJason Bednar$1594% downsideOpen
2026-04-14RBC Capital$1755.7% upsideOpen
2026-04-10Goldman SachsDavid Roman$1670.8% upsideOpen
2026-02-10RBC CapitalShagun Singh$1723.9% upsideOpen
2026-02-10BarclaysMatt Miksic$20222% upsideOpen
2026-02-10Piper Sandler$1702.6% upsideOpen
2026-01-28Piper SandlerJason Bednar$161.162.7% downsideOpen
2026-01-07Stifel Nicolaus$169.032.1% upsideOpen
2025-12-17RBC Capital$165.090.3% downsideOpen
2025-12-02Morgan StanleyPatrick Wood$165.090.3% downsideOpen
2025-04-23Piper SandlerJason Bednar$204.423.4% upsideOpen
2024-10-01Evercore ISIVijay Kumar$227.9937.7% upsideOpen
2024-10-01CitigroupJoanna Wuensch$216.1930.5% upsideOpen
2024-08-02Raymond JamesJayson Bedford$212.2628.2% upsideOpen
2024-08-02Wells FargoLarry Biegelsen$220.1332.9% upsideOpen
2024-07-02Evercore ISIBecton Dickinson$224.0635.3% upsideOpen
2024-05-30Goldman SachsDavid Roman$215.4130.1% upsideOpen
2024-05-06BarclaysMatt Miksic$245.2848.1% upsideOpen
2024-04-08Argus ResearchDavid Toung$235.8542.4% upsideOpen
2023-01-06Morgan Stanley$227.9937.7% upsideOpen
2022-12-12Citigroup$196.5418.7% upsideOpen
2022-11-23Goldman Sachs$213.8429.1% upsideOpen
2022-08-16Goldman Sachs$250.7951.4% upsideOpen
2022-07-18Stifel Nicolaus$220.1332.9% upsideOpen
2022-07-15Morgan Stanley$213.8429.1% upsideOpen
2022-07-11Citigroup$184.7511.6% upsideOpen
2022-06-25Wells FargoLarry Biegelsen$231.9240% upsideOpen
2022-05-06Morgan Stanley$221.733.9% upsideOpen
2022-05-06Piper Sandler$200.4721% upsideOpen
2022-03-03Bank of America SecuritiesTravis Steed$227.9937.7% upsideOpen
2022-02-03Piper SandlerJason Bednar$208.3325.8% upsideOpen

Becton Dickinson (BDX) FAQ

The latest target price for BDX is $180. Investors often review this figure alongside Becton Dickinson's historical trend and sector peers before judging valuation or financial health.

Becton Dickinson trades near $165.62 while the consensus target sits at $180 (8.2% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting BDX's target price ($180), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Becton Dickinson's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.